The FFRangio System enables non-invasive, objective functional evaluation of multi-vessel coronary artery disease and receives FDA clearance.- CathWorks, 07-Jan-19

CathWorks announced that its FFRangio System received FDA 510(k) clearance. The FFRangio system demonstrated accuracy versus the invasive FFR wire...